ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,000 | -76.5% | 3,028 | -75.8% | 0.00% | – |
| Q4 2020 | $17,000 | +240.0% | 12,491 | +236.0% | 0.00% | – |
| Q3 2020 | $5,000 | -28.6% | 3,718 | -42.8% | 0.00% | – |
| Q2 2020 | $7,000 | -99.2% | 6,497 | -98.5% | 0.00% | – |
| Q4 2019 | $907,000 | -10.1% | 429,750 | -6.3% | 0.00% | – |
| Q3 2019 | $1,009,000 | +5835.3% | 458,472 | +6910.3% | 0.00% | – |
| Q2 2019 | $17,000 | -95.1% | 6,540 | -93.5% | 0.00% | – |
| Q1 2019 | $348,000 | -79.5% | 100,000 | -86.4% | 0.00% | -100.0% |
| Q4 2018 | $1,696,000 | +1156.3% | 734,600 | +1582.8% | 0.00% | – |
| Q4 2016 | $135,000 | +13400.0% | 43,653 | +26356.4% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -83.3% | 165 | -72.5% | 0.00% | – |
| Q2 2014 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |